CCL2 and glomerulosclerosis: This disruption promotes lipid accumulation and macrophage foam cell formation, leading to the sustained release of pro-inflammatory cytokines such as TNF-α, IL-1β, and MCP-1, which accelerate glomerulosclerosis and tubulointerstitial fibrosis.